Synopsis of recent research by authors named "Amy L Dunn"
Amy L. Dunn's recent research focuses primarily on improving treatment outcomes and quality of care for pediatric and adult patients with bleeding disorders, particularly hemophilia.
Key findings include the successful implementation of strategies to enhance hemostatic response assessments for DDAVP challenges and improved coagulation factor dosing in emergency settings.
Additionally, Dunn has contributed to important studies concerning novel therapies such as efanesoctocog alfa and valoctocogene roxaparvovec, demonstrating their efficacy and safety in managing severe hemophilia A, alongside efforts to identify research priorities to improve health equity for individuals affected by inherited bleeding disorders.
